Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia

NCT01446055 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Critical Limb Ischemia
Peripheral Arterial Disease
Buerger's Disease

Interventions

DEVICE: ResQ processed bone marrow sample
DEVICE: Ficoll conventional cell processing method

Sponsor

Xuanwu Hospital, Beijing

Collaborators

[object Object]
[object Object]